![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
International Flavors & Fragrances is the largest specialty ingredients producer globally. The company sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver cus... International Flavors & Fragrances is the largest specialty ingredients producer globally. The company sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations, partnering with customers to deliver custom solutions. The nourish segment, which generates roughly half of revenue, is a leading flavor producer and also sell texturants, plant-based proteins, and other ingredients. The health and biosciences business, which generates around one fourth of revenue, is a global leader in probiotics and enzymes. IFF is also one of the leading fragrance producers in the world. The firm also sells pharmaceutical ingredients such as excipients and time-release polymers. Show more
IFF (NYSE:IFF) today announced that it will release its second quarter 2024 earnings results following the market close on Tuesday, August 6, 2024. The management team will host a live webcast on...
IFF Expands the Launch of Industry-leading Poultry Solutions in the EU PR Newswire NEW YORK, June 26, 2024 Two newly approved solutions, Axtra® XAP and Syncra® AVI deliver superior technical and...
IFF (NYSE: IFF) today announced the appointment of Margarita Paláu-Hernández to its Board of Directors, effective June 3, 2024. Paláu-Hernández joins as a mutually agreed independent Director in...
Last year, more than 90% of all new IFF innovations included a sustainability value proposition that supports people and the planet. IFF (NYSE:IFF) today released its 2023 Do More Good Report...
IFF to Unveil Breakthrough Alginate Technologies for Biomedical Innovation at WBC and TERMIS PR Newswire NEW YORK, May 27, 2024 NEW YORK, May 27, 2024 /PRNewswire/ -- IFF (NYSE: IFF), a global...
IFF Unveils Its Controlled Release Platform Featuring Its Innovation and Trailblazing Excipients PR Newswire NEW YORK, May 15, 2024 IFF Pharma Solutions will shine a light on its technology...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 3.12 | 3.33013128402 | 93.69 | 97.72 | 93.307 | 945498 | 95.74621585 | CS |
4 | 0.39 | 0.404480398258 | 96.42 | 98.67 | 92.66 | 1466262 | 95.75948894 | CS |
12 | 14.74 | 17.9602778116 | 82.07 | 99.91 | 81.85 | 1566665 | 93.62854383 | CS |
26 | 17.14 | 21.5137441948 | 79.67 | 99.91 | 72.94 | 1978007 | 85.38068368 | CS |
52 | 18.15 | 23.0739893211 | 78.66 | 99.91 | 62.11 | 2046044 | 78.4745923 | CS |
156 | -52.66 | -35.2311500636 | 149.47 | 157.48 | 62.11 | 1743485 | 99.91597153 | CS |
260 | -45.2 | -31.8287444546 | 142.01 | 157.48 | 62.11 | 1746951 | 110.13969028 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions